Immune Effects on the Blood — Low Counts and Clotting Problems
Immunotherapy can, uncommonly, cause the immune system to lower red cells, white cells or platelets — or, occasionally, raise clotting risk instead. These immune-related blood changes are uncommon and are often first attributed to the wrong cause, since chemotherapy, the cancer itself, or infection are far more likely explanations. NCCN and ASCO guidance on immune-related adverse events treats unexplained bleeding, severe fatigue, fever, or signs of a clot during immunotherapy as findings that need same-day blood work, not a wait-and-watch approach.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Uncommon, easily missed — immune-related low counts affect a small proportion of patients and are often mistaken for treatment fatigue.
- Not always the treatment — chemotherapy, marrow involvement, infection and nutrition are checked first.
- Can go either way — the same immune activation can lower counts or, rarely, raise clotting risk instead.
- Go to the ER for red flags — uncontrolled bleeding, fever, sudden weakness or leg swelling need emergency care.
on Panel
Survival Rate*
Treated
(800+ reviews)
How Urgent Is a Low Blood Count or Clotting Problem on Immunotherapy?
Most abnormal blood counts during immunotherapy are mild and are managed with monitoring or a short pause in treatment. But a small number of symptoms point to severe bleeding, dangerous infection, or a blood clot forming — and these need emergency evaluation the same day, not a wait-and-see approach, because they can worsen within hours.
Go to the ER now, or call an ambulance, if you have any of these:
- Bleeding that will not stop, or blood in vomit, stool or urine
- Fever or chills of any kind during immunotherapy
- Sudden breathlessness, chest pain, or a racing heartbeat
- Sudden one-sided weakness, slurred speech, or a severe new headache
- New painful swelling, redness or warmth in one leg
For any other abnormal blood test result or new bruising during immunotherapy, call the CION helpline the same day:
Call the CION Helpline Now: 1800 202 8726Which Blood Counts Can Fall During Immunotherapy?
Immunotherapy can occasionally lower red blood cells, white blood cells or platelets — or, rarely, do the opposite and raise clotting risk. Each pattern looks different day to day, so the table below separates what is usually ordinary treatment tiredness or a minor bruise from a pattern that needs urgent review.
| Feature | Usually ordinary (monitor, mention at next visit) | Possible immune-related change — needs urgent review |
|---|---|---|
| Tiredness | Comes on with exertion, improves with rest, matches your usual treatment pattern | New or worsening fatigue with paleness or breathlessness at rest — can mean low red cells (anaemia) |
| Bruising or bleeding | A single small bruise from a known knock, gums bleed briefly when brushing | Bruising with no known cause, tiny red or purple spots on the skin, or bleeding that is heavier or longer than usual — can mean low platelets |
| Fever | Not applicable — any fever during immunotherapy is checked, never assumed minor | Fever or chills, even without other symptoms — can mean dangerously low white cells (neutropenia) |
| Leg or chest symptoms | Mild ankle puffiness after a long day, that settles overnight | New swelling, pain or warmth in one leg, or sudden breathlessness or chest pain — can mean a blood clot |
Is It the Treatment or the Cancer Causing My Low Counts?
Low blood counts during cancer care are common, and an immune reaction to immunotherapy is one of the least likely explanations. Your oncology team works through the more common causes first, which is why a low count on a routine test is rarely a reason for alarm on its own.
| Possible cause | What's typically happening | How it's told apart |
|---|---|---|
| Chemotherapy (if also being given) | Bone marrow production slows temporarily, in a predictable pattern after each cycle | Counts follow a known "nadir" timeline and recover before the next cycle |
| Cancer involving the bone marrow | The cancer itself, or its spread, reduces the marrow's ability to make blood cells | Counts fall gradually over weeks; a bone marrow sample can confirm involvement |
| Infection or nutritional deficiency | A separate infection, or low iron/B12/folate, lowers one or more counts | Screened for with routine blood tests alongside symptoms like fever or diet history |
| Immune-related cytopenia (uncommon) | The immune system, activated by immunotherapy, attacks blood cells or raises clotting risk directly | A diagnosis of exclusion — considered once the more common causes above don't explain the pattern |
How Soon Can This Appear After Starting Immunotherapy?
Unlike some immune reactions that cluster in the first few weeks, immune-related blood count changes can appear at almost any point during treatment — early on or after many months of otherwise uneventful cycles. This unpredictable timing is why routine blood counts are checked before every immunotherapy cycle, not only at the start of treatment.
| Stage | What's typically happening |
|---|---|
| Typically starts | Can occur at any point during immunotherapy — there is no single "high-risk window" the way there is for some other immune reactions. |
| Early phase | Often picked up on a routine pre-cycle blood test before any symptom is noticed. |
| If unreported | Can progress to significant bleeding, infection, or a blood clot over hours to a few days if a symptom such as bruising, fever or leg swelling is ignored. |
Because this reaction can appear without warning, the safest approach is routine pre-cycle blood testing throughout treatment plus prompt reporting of any new bruising, bleeding, fever or leg swelling — not waiting for a scheduled visit.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Don't Ignore an Abnormal Blood Count on Immunotherapy
Our tumour board includes the same specialists managing your immunotherapy — reach them directly.
How Are Immune-Related Low Blood Counts and Clotting Problems Managed?
Once other causes have been checked, management is matched to how severe the change is — most cases are handled with monitoring or a temporary pause, and only the more significant drops need steroids, transfusion or clot-preventing treatment.
- 1
Repeat blood tests, promptly
An abnormal count is rechecked quickly, alongside tests that look for infection, iron or vitamin deficiency, and marrow involvement.
- 2
Ruling out more common causes
Chemotherapy effects, infection and nutritional causes are excluded before an immune reaction is considered — this is standard practice, not a delay.
- 3
Mild changes: closer monitoring
If the drop is small and you have no red-flag symptoms, immunotherapy often continues with more frequent blood tests.
- 4
Moderate to severe: pause and treat
More significant drops usually mean pausing immunotherapy, starting steroids, and bringing in a haematologist; a transfusion or clot-preventing treatment is given if needed.
- 5
Deciding on immunotherapy going forward
Once counts recover, your tumour board decides whether to restart immunotherapy, adjust the plan, or consider an alternative approach, based on how severe the reaction was.
Rare Reactions Are Manageable When Caught Early
Patients who report new bruising, bleeding, fever or leg swelling promptly are supported by the same multidisciplinary team throughout treatment.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Low Blood Counts and Clotting on Immunotherapy: Your Questions Answered
Which blood counts can fall during immunotherapy?
Immunotherapy can occasionally lower red blood cells (causing anaemia), white blood cells (raising infection risk), or platelets (raising bleeding risk), either alone or together. Rarely, the immune system also increases clotting risk instead of, or alongside, low counts. Which count is affected changes the symptoms to watch for and the tests your oncology team orders, so any abnormal report is reviewed against your specific pattern rather than treated as one generic problem.
Is my low blood count caused by the treatment or by the cancer itself?
Both are possible, and it is not usually obvious from symptoms alone. Chemotherapy, cancer involving the bone marrow, nutritional deficiency and infection are all far more common causes of low counts than an immune reaction to immunotherapy. Immune-related cytopenia is uncommon and is generally diagnosed only after these more common causes have been checked and ruled out with blood tests, and sometimes a bone marrow sample.
How are immune-related low blood counts and clotting problems managed?
Management starts with repeat blood tests and ruling out other causes such as infection or marrow involvement. Mild changes may simply be monitored more closely while immunotherapy continues. Moderate to severe cases usually mean pausing immunotherapy, starting steroids under a haematologist's input, and giving a transfusion or clot-preventing treatment if needed, with the decision to restart immunotherapy made once counts recover.
What blood-count or clotting symptoms need emergency care right away?
Go to the nearest emergency room or call an ambulance for: bleeding that will not stop, blood in vomit, stool or urine, a fever with chills during immunotherapy, sudden severe breathlessness or chest pain, sudden one-sided weakness, slurred speech or a severe new headache, or new painful swelling in one leg. These can signal severe bleeding, infection with low white cells, or a blood clot, and are treated as emergencies without waiting to see if they settle.
Can immunotherapy cause blood clots as well as low blood counts?
Yes, though it is uncommon. Alongside lowering red cells, white cells or platelets, the same immune activation can occasionally raise clotting risk instead. Warning signs include new swelling, pain or warmth in one leg, or sudden breathlessness and chest pain, which can indicate a clot in the leg or lungs and always need same-day emergency assessment, not home monitoring.
Will low blood counts mean immunotherapy has to be stopped?
Not always. Mild, immune-related count changes are often manageable with closer monitoring while treatment continues. More significant drops usually mean a temporary pause while the levels recover with steroids or supportive care. Whether immunotherapy restarts, continues at a lower intensity, or is stopped altogether depends on how severe the reaction was and is decided by your tumour board on a case-by-case basis.